Insulin Therapy for Obese Women with Gestational Diabetes

Introduction to Insulin Therapy

The American Diabetes Association recommends insulin as the preferred pharmacological treatment for gestational diabetes (GDM) in women who cannot control blood sugar with lifestyle modifications alone, with insulin being the safest and most effective option for an obese pregnant woman of 120kg in the third trimester 1

The American Diabetes Association recommends the following glycemic targets for adequate control of GDM: fasting blood sugar <95 mg/dL, 1-hour postprandial blood sugar <140 mg/dL, and 2-hour postprandial blood sugar <120 mg/dL 1, 2

The initial approach to managing GDM includes an individualized meal plan with a minimum of 175g of carbohydrates, 71g of protein, and 28g of fiber per day, as recommended by the American Diabetes Association 2
The American Diabetes Association also recommends distributing carbohydrates into three small to moderate meals and two to four snacks throughout the day 3
Moderate physical activity (20-50 minutes per day, 2-7 days per week) is recommended as tolerated, with daily monitoring of blood sugar and food records to adjust the treatment plan 2, 3

Insulin therapy is indicated when glycemic targets are not met with lifestyle modifications alone, with obese women with GDM in the third trimester frequently requiring insulin due to increased insulin resistance 1, 4
The initial total daily insulin dose is calculated as 0.7-1.0 units/kg of current weight, with a dose of approximately 0.8 units/kg recommended for a 120kg woman in the third trimester 5

The American Diabetes Association recommends the following insulin regimen: 40% of the total daily dose as basal insulin (NPH or long-acting analogs) and 60% as prandial insulin (regular or rapid-acting analogs) 5
Basal insulin is administered in two doses: 2/3 in the morning and 1/3 at night, while prandial insulin is distributed before main meals, with 20 units at breakfast, 19 units at lunch, and 19 units at dinner 3, 5

Daily monitoring of fasting and postprandial blood sugar is recommended, with weekly adjustments of insulin doses as needed, increasing by 10-20% if targets are not met 1, 5
In the third trimester, insulin resistance increases exponentially, requiring more frequent adjustments to the insulin regimen 5

The American Diabetes Association recommends avoiding hypoglycemia by providing guidance on recognition and treatment, monitoring ketonuria to prevent fasting ketosis, and including a bedtime snack to prevent hypoglycemia and accelerated ketosis during the night 1, 3
A snack containing carbohydrates may be necessary before or during breastfeeding after delivery 3

Weekly or biweekly evaluation of insulin doses is recommended in the third trimester due to the rapid increase in insulin resistance, with monitoring of gestational weight gain and adjustment of the insulin regimen after delivery 5, 6

Insulin does not cross the placenta in measurable amounts, making it safer than oral hypoglycemics, according to the American Diabetes Association 7
Metformin and glyburide are not recommended as first-line treatments due to their ability to cross the placenta and lack of long-term safety data, as stated by the American Diabetes Association 1
Approximately 70-85% of women with GDM can control blood sugar with lifestyle modifications alone, but obese women often require pharmacotherapy, as recommended by the American Diabetes Association 1, 2